Allergens

6 trials

Sponsors

National Biopreparations Center (BIOCEN), National Center of Bioproducts (BioCen), National Center of Bioproducts (BioCen)

Conditions

AsthmaBronchial asthma

Phase 2

Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults

Active, not recruitingRPCEC00000027

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2003-03-17Updated: 2026-03-30

Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults

Active, not recruitingRPCEC00000026

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2003-03-16Updated: 2026-03-30

Efficacy of VALERGEN-BT sublingual vaccine in asthmatic adults.

Active, not recruitingRPCEC00000029

National Biopreparations Center (BIOCEN)Asthma

Start: 2005-09-07Updated: 2026-03-30

Subcutaneous immunotherapy with PROLINEM-DS-Asthma- Adults-Fase II

RecruitingRPCEC00000278

National Center of Bioproducts (BioCen)Asthma

Start: 2019-04-30Target: 60Updated: 2026-03-30

VALERGEN-combination of routes- Asthma-Adults-Phase II

Active, not recruitingRPCEC00000298

National Center of Bioproducts (BioCen)Asthma

Start: 2020-07-01Target: 180Updated: 2026-03-30

Phase 3

Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults.

Active, not recruitingRPCEC00000028

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2003-03-16Updated: 2026-03-30

Related Papers

Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized <i>Blomia tropicalis</i> vaccine.

2020-04-109 citations